Risk Factors for Loss to Follow-up of ARV Therapy among HIV/AIDS-infected Patients at Paniai Regency Public Hospital, Central Papua Province

Authors

  • Beny Degei Postgraduate Master Program of Public Health, Faculty of Public Health, Cenderawasih University
  • Arius Togodly Faculty of Public Health, Cenderawasih University, Jayapura Papua, Indonesia, 99351
  • Sarce Makaba Faculty of Public Health, Cenderawasih University, Jayapura Papua, Indonesia, 99351
  • Novita Medyati Faculty of Public Health, Cenderawasih University, Jayapura Papua, Indonesia, 99351
  • Hasmi Faculty of Public Health, Cenderawasih University, Jayapura Papua, Indonesia, 99351
  • Yacob Ruru Department of Statistics, Faculty of Mathematics and Natural Sciences, Cenderawasih University

Keywords:

Risk Factors, Loss to Follow-up, ARV, HIV/AIDS

Abstract

Background: Human Immunodeficiency Virus (HIV) infection and AIDS are worldwide issues. In 2018, there were 37.9 million HIV-positive persons worldwide. In Indonesia, 88% of patients (244,142) who had received antiretroviral (ARV) were reported to have been lost to follow up, with up to 23% (55,508) being lost to follow up. Data from Paniai Regency Public Hospital, which is recorded up to 2021, out of 486 who have had ARV therapy, there are 169 (34.8%) loss to follow-up. Objectives: This study aimed to determine risk factors for loss to follow-up of antiretroviral (ARV) therapy among HIV/HIV-infected patients in Paniai Public Hospital, Paniai Regency, Central Papua Province. Methods: This type of research is analytic with a cross sectional study approach. The population is all HIV/AIDS patients receiving ARV therapy with a total sample of 190 people. Data were retrieved from medical record fields. Data were analyzed using chi square, at a significant level of 5%. Result: The results showed that the factors associated with loss to follow-up of ARV therapy at Paniai Regency Public Hospital were education (p-value 0.000; RP = 3.344; 95% CI (2.023 – 5.528), and occupation (p-value 0.000; RP = 2.338, 95% CI (1.663 – 3.288), while factors that were not related to loss to follow-up of ARV therapy were gender (p-value 0.310 or p > ? (0.05); RP; 1.227; 95% CI (0.869 – 1.731) and duration of treatment (p-value 0.473; RP = 0.811; 95% CI (0.531–1.238).

References

M. Rahmawati; 2019. Penanggulangan HIV/AIDS di Indonesia dalam Ancaman RKUHP. Jakarta: Institute for Criminal Justice Reform (ICJR).

Ministry of Health of Republic of Indonesia; 2019. Laporan Perkembangan Hiv Aids Dan Penyakit Infeksi Menular Seksual (PIMS). Jakarta.

A. Rosiana, and M. Sofro; 2014. Faktor – Faktor Yang Mempengaruhi Lost To Follow-Up Pada Pasien Hiv/Aids Dengan Terapi Arv Di Rsup Dr Kariadi Semarang. Jurnal Kedokteran Diponegoro. 3(1): 111495.

Zürcher, K., Mooser, A., Anderegg, N., Tymejczyk, O., Couvillon, M. J., Nash, D. dan Egger, M. 2017. Outcomes of HIV-positive patients lost to follow- up in African treatment programmes. Tropical medicine & international health : TM & IH. 22(4): 375–387.

Spritia; 2021. Terapi ARV Hanya Redam Virus HIV, Bukan Memberantas. [Access 2023, Feb 9]. Available from: https://spiritia.or.id/informasi/detail/385

Paniai Regency Public Hospital; 2022. Laporan Tahunan RSUD Paniai Tahun 2021. Enarotali.

S. Adiningsih; 2018. CD4+ dan Faktor yang Memengaruhi Kepatuhan Terapi Antiretroviral pada Orang dengan HIV/AIDS di Jayapura. Buletin Penelitian Kesehatan, Vol. 46, No. 2, Juni 2018: pp. 87 – 96.

E. Kusdiyah; 2022. Faktor-Faktor Yang Berhubungan Dengan Kepatuhan Pasien HIV Dalam Mengonsumsi Terapi Antiretroviral di Puskesmas Simpang Kawat Kota Jambi. e-SEHAD, Volume 3, Nomor 1, Juli 2022, pp. 08-27

S.R. Berlianty; 2018. Faktor-Faktor Yang Berhubungan Dengan Kejadian Lost To Follow-Up Pada Terapi Antiretroviral. Semarang: Fakultas Ilmu Keolahragaan Universitas Negeri Semarang.

L. Handayani; 2017. Faktor risiko loss to follow-up terapi ARV pada pasien HIV. Berita Kedokteran Masyarakat vol 33(4); pp. 173-180.

S. Notoatmodjo; 2018. Ilmu Kesehatan Masyarakat. Jakarta: Rineka Cipta.

L. Manowati; 2019. Faktor Yang Mempengaruhi Perilaku Loss to Follow-up Pada Pasien HIV/AIDS Dengan Terapi ARV di RSUD Dr. Soetomo Surabaya [Access 2023, Feb 9]. Available from: https://Repository.unair.ac.id/84098/

R.N. Fadillah; 2021. Faktor Yang Berhubungan Dengan Kepatuhan Minum Obat Antiretroviral (ARV) Pada Orang Dengan HiIV/AIDS (ODHA) di Kota Palopo Tahun 2020. Makassar: Fakultas Kesehatan Masyarakat Universitas Hasanuddin.

S. Fauziah; 2019. Identifikasi Faktor-Faktor Penyebab Drop-Out ARV Pada Penderita TB-HIV di Kelompok Dukungan Sebaya Arjuna Semarang. Jurnal Kesehatan Masyarakat, vol. 7(1), pp. 519 – 526.

Priyoto; 2014. Teori Sikap & Perilaku dalam Kesehatan Dilengkapi Contoh Kuesioner. Yogyakarta: Nuha Medika.

Pania Regency Helath Office; 2022. Profil Kesehatan Kabupaten Paniai. Enarotali

N. Sigalingging; 2022. Determinan kepatuhan minum obat ARV pada penderita dengan HIV/AIDS di Kota Jambi. Media Kesehatan Masyarakat, vol 4(2), pp. 273-283.

Downloads

Published

2023-02-21

How to Cite

Beny Degei, Arius Togodly, Sarce Makaba, Novita Medyati, Hasmi, & Yacob Ruru. (2023). Risk Factors for Loss to Follow-up of ARV Therapy among HIV/AIDS-infected Patients at Paniai Regency Public Hospital, Central Papua Province. International Journal of Sciences: Basic and Applied Research (IJSBAR), 67(1), 347–355. Retrieved from https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/15417

Issue

Vol. 67 No. 1 (2023)

Section

Articles

License

Copyright (c) 2023 International Journal of Sciences: Basic and Applied Research (IJSBAR)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who submit papers with this journal agree to the following terms.